N
CHRS icon

Natixis’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Natixis’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,500
Closed -$235K – 1049
2022
Q3 		$235K Buy
+24,500
New +$235K ﹤0.01% 914